175 related articles for article (PubMed ID: 35959801)
21. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
Ni J; Guo Z; Zhang L
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer.
Wang L; Wang D; Zheng G; Yang Y; Du L; Dong Z; Zhang X; Wang C
Int J Biol Markers; 2016 Feb; 31(1):e80-7. PubMed ID: 26560853
[TBL] [Abstract][Full Text] [Related]
23. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
24. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients].
Hang ZQ; Zheng MF; Huang JH
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Diagnostic Value of CTC and CTDNA in Early Lung Cancer.
Hongwei Yao ; Lixin Wen ; Ziyan Li ; Chunwei Xia
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):57-62. PubMed ID: 37605590
[TBL] [Abstract][Full Text] [Related]
26. Effects of miR-221 on the apoptosis of non-small cell lung cancer cells by lncRNA HOTAIR.
Sun YJ; Li J; Chen CH
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4226-4233. PubMed ID: 31173294
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic Changes of LncRNA Hotair in Non-Small-Cell Lung Cancer and Its Clinical Application.
Huang H; Wang J; Liu F
J Healthc Eng; 2021; 2021():3215143. PubMed ID: 34777731
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
Chen ZQ; Huang LS; Zhu B
Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Serum LncRNA HOTAIR in Non-small Cell Lung Cancer
and Its Clinical Significance].
Tan N; Li L; Bai L; Zhao K
Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):402-406. PubMed ID: 28641698
[TBL] [Abstract][Full Text] [Related]
30. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
31. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
Wang P; Piao Y; Zhang X; Li W; Hao X
Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Elsayed RS; Sherif MM; Abbas A; El Shabrawy M
J Gene Med; 2021 Dec; 23(12):e3381. PubMed ID: 34312940
[TBL] [Abstract][Full Text] [Related]
33. Exploration and analysis of the value of tumor-marker joint detection in the pathological type of lung cancer.
Gao S; Zhang G; Lian Y; Yan L; Gao H
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):93-97. PubMed ID: 33040792
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of the combined detection of CEA, NSE and IL-18 for lung cancer and their relationship with apoptosis gene Bcl-2.
Gu RH; Tan B; Ma J; Shen WY; Zuo YS; Shi L
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1637-1646. PubMed ID: 33108861
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
38. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
Zhu K; Chen L; He C; Lang Y; Kong X; Qu C; Xu S
Dis Markers; 2020; 2020():6430459. PubMed ID: 32089756
[TBL] [Abstract][Full Text] [Related]
39. Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non-Small Cell Lung Cancer.
Li N; Wang Y; Liu X; Luo P; Jing W; Zhu M; Tu J
Technol Cancer Res Treat; 2017 Dec; 16(6):1060-1066. PubMed ID: 28784052
[TBL] [Abstract][Full Text] [Related]
40. Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
Dou X; Lu J; Yu Y; Yi Y; Zhou L
Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
